Clin2
NCT07731256Possibly a fitNot yet recruiting

Semaglutide for chronic low back pain

Lower Back PainObesity (BMI>30)Chronic Lower Back Painglp1 Agonist

Treatments studied

Part of Hormones & metabolism, Pain clinical trials.

This study tests whether semaglutide, a medicine used for weight loss and diabetes, can reduce chronic low back pain in people with a higher body mass index (BMI). It may help by reducing weight-related stress on the spine and decreasing inflammation.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
250 people
Ages
18 years to 85 years
Study type
Interventional

Who can take part

  • Are between 18 and 85 years old
  • Have had low back pain for at least 3 months, with a typical severity of at least 4 out of 10
  • Have a body mass index (BMI) between 30 and 49 (body mass index is a measure of weight relative to height)
  • Are not pregnant or breastfeeding and, if of childbearing age, agree to use effective birth control
  • Do not have diabetes requiring medication (except metformin) or an HbA1c above 7
  • Do not have conditions like recent heart attack, stroke, severe heart failure, pancreatitis, kidney disease, or active cancer

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06825793Not yet recruiting
Semaglutide for weight loss in obesity

This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.

NCT07513168Recruiting· Phase 4
Low-dose semaglutide for weight loss in obese adults

This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.

Hyderābād, Sindh
NCT06909006Not yet recruiting· Phase 3
Semaglutide for adults with type 1 diabetes and overweight

This study tests whether semaglutide, a medicine that helps control blood sugar and reduce weight, can benefit adults with type 1 diabetes who are overweight. If you qualify, you may receive the drug or a placebo, and the study team will monitor your health closely.

Hillerød, Denmark
NCT06937060Recruiting· Phase 3
Semaglutide for psoriasis and obesity

This trial tests if semaglutide, a medicine used for diabetes and weight loss, can help people with both psoriasis and obesity. You may qualify if you have moderate to severe psoriasis, a high body weight, and are of Chinese descent.

Hong Kong
NCT07323134Not yet recruiting
Semaglutide and gut bacteria in people with obesity

This study tests whether a medication called semaglutide (which helps with weight loss) can change the bacteria in your gut, which might play a role in weight regulation. By participating, you may receive a treatment that could help you lose weight while researchers learn more about how it works.

NCT06616961Not yet recruiting· Phase 3
Semaglutide for weight loss in overweight or obese adults

This trial tests a medicine called semaglutide (often used for diabetes) to see if it helps people in Bangladesh who are overweight or obese lose weight. The study will check if the medicine is safe and effective for both people with and without type 2 diabetes.

Dhaka

Hear when a new Lower Back Pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.